Ramdev Allopathy Row: Complaints “Sponsored”, Says Centre as Chhattisgarh Police Files Closure Report in Supreme Court

The Supreme Court was informed that Chhattisgarh Police filed a closure report in the case over yoga guru Ramdev’s remarks on allopathy during Covid. The Centre said complaints appeared “sponsored,” while the matter is now adjourned to December.

Ramdev vs State | “Digital Crimes Of Sharing Indecent/Nude Pictures Can Destroy Lives”: Allahabad HC Refuses Bail In WhatsApp Case

The Allahabad High Court denied bail to a man named Ramdev accused of sharing indecent images of a woman on WhatsApp. The Court emphasized how social media crimes can ruin lives and called for a speedy trial.

Misleading Ads | SC Stays Ayush Ministry’s Notification Removing Rule 170 of Drugs and Cosmetics Rules, 1945

Today(27th August), The Supreme Court of India has stayed the Central government’s notification omitting Rule 170 of the Drugs and Cosmetics Rules, 1945, which prevents misleading advertisements for Ayurvedic, Siddha, and Unani drugs. Justices Hima Kohli and Sandeep Mehta criticized the Ministry of Ayush for removing the rule despite a prior court order to maintain it.

Ramdev Claims “Allopathy Medicines as Poisonous and Blaming them for Deaths of Millions” After Supreme Court Reprimand

Renowned yoga guru Ramdev’s controversial comments on allopathy medicines, labeling them “poisonous” and attributing millions of deaths to their consumption, have reignited the traditional versus modern medicine debate. This follows a recent Supreme Court case where Ramdev and his company, Patanjali Ayurved, faced contempt proceedings for misleading advertisements about their products.

“Unsubstantiated Claims” | Delhi HC to Pronounce Order on Doctors’ Plea Against Ramdev’s ‘Coronil’ COVID-19 Cure Claim Today

Today(on 29th July), The Delhi High Court will rule today on a petition by doctors’ associations challenging Ramdev’s claim that ‘Coronil’ cures COVID-19. The petition, part of a 2021 lawsuit against Ramdev and Patanjali Ayurveda, follows Justice Bhambhani’s reserved decision from May 21.

Patanjali Row | “We Rarely Take Action, Don’t Have an Ego”: SC on IMA President’s Comments Against it

The Supreme Court Today (May 14th) said that it was not convinced by the apology affidavit submitted by Indian Medical Assocation (IMA) President Dr RV Asokan over his comments criticising the Court in an interview.

Patanjali Ayurved & IMA | SC Grills Central Government on Directive to AYUSH Authorities Regarding Misleading Ads

The Supreme Court Today (May 7th) questioned the Central government’s directive to AYUSH authorities, asking why they were instructed not to act against misleading advertisements under Rule 170 of the Drugs and Cosmetics Rules, 1945. The inquiry came during a hearing of a plea filed by the Indian Medical Association (IMA) against an alleged smear campaign by Patanjali Ayurved and its founders Baba Ramdev and Acharya Balkrishna, targeting the COVID-19 vaccination drive and modern medicine.

[Patanjali Row] Uttarakhand Licensing Body Apologizes to SC | Cancels Licences of 14 Products

On Monday(29th April),The Uttarakhand licensing authority suspended licenses for 14 Patanjali Divya Pharmacy products due to misleading ads. The Supreme Court will address Ramdev and Acharya Balkrishna’s published apology today(on April 30th).

[BREAKING] Ramdev, Patanjali Publish New and ‘BIGGER’ Apology Today | A Day After SC Rap

Following a Supreme Court reprimand, Patanjali co-founders Ramdev and Balkrishna issued a new, more prominent public apology in newspapers, acknowledging their non-compliance with court directions and vowing to rectify their mistakes. The apology addresses misleading advertisements and emphasizes their commitment to abide by the court’s instructions. The court scheduled a hearing on April 30 to review the matter.

Patanjali ads: Ramdev, Balkrishna tender unconditional apology before SC

Today (9th, April), Yoga guru Ramdev and Patanjali Ayurved Ltd’s Managing Director Acharya Balkrishna submitted an “unconditional and unqualified apology” to the Supreme Court for exaggerating product claims. The court previously criticized their apologies, emphasizing adherence to legal commitments. The Supreme Court (SC) is set to hear the case on April 10th.